No change to STI constituents following June review

STRAITS Times Index (STI) administrator FTSE Russell announced on Thursday (June 6) that there will be no changes to the constituents of Singapore’s blue-chip index following the June 2022 quarterly review.

The STI reserve list, comprising the 5 highest ranking non-constituents of the STI by market capitalisation, will be, in order of size: Olam International, Suntec Reit, Keppel Reit, Frasers Centrepoint Trust and Mapletree North Asia Commercial Trust.

Stocks on the reserve list will replace any constituents that become ineligible as a result of corporate actions before the next review, which will take place in September 2022.

FTSE Russell partners the Singapore Exchange and SPH Media Trust, which publishes The Straits Times and The Business Times, to jointly calculate the STI.

Singapore's main stock market benchmark, the STI, is used as the basis for a range of financial products including exchange traded funds (ETFs), warrants, futures and other derivatives.

The index is reviewed quarterly in accordance with the index ground rules and to facilitate the inclusion of eligible initial public offering stocks.